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It is well-known that amelogenin self-assembles to form nanoparticles, usually referred to as amelogenin
nanospheres, despite the fact that not much is known about their actual shape in solution. In the current paper, we
combine SAXS and DLS to study the three-dimensional shape of the recombinant amelogenins rP172 and rM179.
Our results show for the ﬁrst time that amelogenins build oblate nanoparticles in suspension using experimental
approaches that do not require the proteins to be in contact with a support material surface. The SAXS studies
give evidence for the existence of isolated amelogenin nano-oblates with aspect ratios in the range of 0.45-0.5
at pH values higher than pH 7.2 and show an aggregation of these nano-oblates at lower pH values. The role of
the observed oblate shape in the formation of chain-like structures at physiological conditions is discussed as a
key factor in the biomineralization of dental enamel.
Introduction
Dental enamel, the most highly mineralized structure in the
vertebrate body, consists of well-ordered arrays of enamel prisms
that are each constructed of parallel bundles of high aspect-
ratio carbonated hydroxyapatite crystals.
1 Unraveling the mech-
anisms behind the formation of this sophisticated, hierarchical
structure is of great interest with respect to understanding the
basis of malformed tooth enamel and the development of new
bioinspired materials for enamel tissue regeneration and repair.
Whereas the migration of ameloblast cells is of crucial
importance for controlling the structural arrangement of enamel
on the micrometer scale and above,
2 the elongated growth and
parallel alignment of the mineral crystals on the length scale of
nanometers is mainly determined by the interaction with
amelogenin proteins and their self-assembly.
1,3 Amelogenins
comprise about 90% of all proteins secreted by ameloblast cells.
4
During the secretory stage of amelogenesis, long thin ribbons
of enamel mineral crystals are formed almost immediately as
the ameloblast lays down enamel matrix proteins, suggesting
that enamel mineralization does not take place within a
preformed matrix.
1 Interestingly, the pH within secretory enamel
has been found to be close to neutrality and within a narrow
range, with average values of pH 7.26 in the pig
5 and pH 7.23
in the rat.
6 As the enamel tissue matures, enamel matrix proteins
are successively degraded
7–9 and removed, allowing the initial
mineral crystals to grow in thickness and in width to produce
an enamel layer that is >95% mineral by weight.
3
Transmission electron microscopy (TEM) investigations of
developing rat incisor enamel
10 using a freeze-fracture technique
revealed that the forming region (youngest enamel) consisted
of globular structures with a diameter of 30-50 nm that were
either randomly or linearly arranged. At a somewhat later stage
of development, these globules appeared to be more linearly
arranged. In regions approaching enamel maturation, mineral
crystallites that were 50-60 nm wide and 5-6 nm thick were
found as closely packed bundles that were 4 µm in diameter.
10
These bundles were assumed to correspond to the enamel
prisms. Based on these observations, the authors concluded that
the organized globules played a role in the ordered growth of
enamel crystals. In vitro studies later demonstrated that recom-
binant murine amelogenins form spherical structures
11,12 with
dimensions similar to those of the globules observed in
developing rat enamel.
10 Based on a comparison of observations
from TEM studies on mouse, bovine, and hamster enamel,
amelogenin nanospheres were postulated to be the main
functional component controlling the crystal growth and spacing
in the forming enamel.
13 The self-assembly of recombinant and
native amelogenins into nanospheres has been thoroughly
investigated by means of dynamic light scattering (DLS)
12,14,15
in combination with atomic force microscopy (AFM)
15,16 and
also using TEM.
11,17 Our own previous in vitro studies combined
DLS and small-angle X-ray scattering (SAXS)
18 to investigate
the recombinant full length murine amelogenin rM179 and its
cleavage product rM166, which lacks the hydrophilic C-terminus
found in the full-length molecule. The results conﬁrmed the
existence of nanosized amelogenin agglomerates in suspensions
and supported a core-shell model for full-length amelogenin,
where the hydrophobic portion of the protein makes up the dense
inner part and the hydrophilic portions corresponding to the
charged C terminus build a loose shell around this core.
Furthermore, we observed a temperature-induced onset of
aggregation of the amelogenin nanoparticles in suspension,
which was strongly inﬂuenced by the presence of the charged
C-terminus.
18 When the same general approach is used,
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ature-dependent self-assembly of murine and porcine amelo-
genins highlighted the importance of the pH value for triggering
the aggregation process. The full length proteins rP172 and
rM179 were found to form higher-order assemblies at pH 7.2.
19
Such higher-order assembly observed by TEM was described
as a linear aggregation of nanospheres to form chains.
19–21
Except for the DLS studies, the results on the assembly of
amelogenin into nanospheres and their aggregation to build
chains, as described above, were obtained using approaches (i.e.,
TEM and AFM) where proteins were immobilized on solid
substrates and dried prior to analyses. For characterization by
means of TEM and AFM, the suspensions were put on mica
surfaces, TEM grids, or similar support materials. However, the
structure of the protein nanoparticles is very likely affected by
such underlying support materials and drying. Hence, it is very
difﬁcult to obtain detailed information on the three-dimensional
(3D) shape of amelogenin nanoparticles by such direct imaging
techniques without inducing possible artifacts. An AFM study
16
has reported deviations from the frequently described spherical
shape, toward a more ﬂat appearance, when ﬁxed samples of
rM179 were examined on mica surfaces, although this point or
its potential importance was not discussed further. Other studies
have described amelogenin aggregates formed from mixtures
of porcine amelogenins
22 and from solutions of recombinant
mouse amelogenins
13,14 as being “quasi-spherical”, based on
TEM and AFM analyses. However, the meaning or relevance
of this nanoparticle description was not discussed. Nevertheless,
it remains that the true nature of amelogenin nanospheres in
suspension has not been fully characterized. DLS studies, which
are based on the diffusion behavior of the particles in suspension,
have provided information on the size of amelogenin nanopar-
ticles and have shown that they are monodispersed
12,18 under
speciﬁed conditions. However, such analyses do not provide
any details on their true shape. When SAXS is used, the 3D
structure of amelogenin nanoparticles in suspension can be
characterized, as our previous SAXS studies on recombinant
murine amelogenins
18 have shown. This initial study provided
evidence that clearly suggested that the full-length recombinant
murine amelogenin formed nanoparticles that deviated from a
spherical shape. The current paper focuses on furthering such
studies by describing the shape of both porcine and murine
amelogenin nanoparticles and their pH-dependent aggregation
by means of SAXS.
Materials and Methods
Protein Preparation. Recombinant murine and porcine amelogenins
rM179 and rP172 were produced in bacteria and puriﬁed as previously
described.
23 In contrast to their native counterparts, the recombinant
amelogenins lack the N-terminal methionine as well as a single
phosphate group at serine-16.
Protein Solution Preparation. Stock solutions with a concentration
of 5 mg/mL were made by dissolving lyophilized proteins in ice-cold
distilled deionized water. The stock solutions were then stored for at
least 24 h at 4 °C prior to use. Experimental solutions with concentra-
tions of 2 mg/mL protein and 80 mM Tris-HCl at selected pH values
were then prepared on ice by diluting protein stock solutions with
buffers that had been preadjusted to desired pH values at either 25 or
37 °C (different values in the range of pH 7-7.8 at 25 °C and pH 7.2
at 37 °C). All buffer solutions and water were ﬁltered prior to use.
The temperature dependence of the Tris-HCl buffer was used to change
the pH of the protein suspensions by means of varying the temperature
between 4 and 37 °C. The pH values given in the tables and graphs
were either measured or calculated using the known temperature
dependence of ∆pH )- 0.03/°C. It has previously been shown that
measured and calculated pH values are in a good agreement.
19
SAXSsInstrumentation. For the SAXS experiments a Nanostar
laboratory instrument (Bruker AXS, Karlsruhe, Germany) was used.
It consists of a sealed X-ray tube which operates at 1.5 kW (40 kV, 35
mA, Cu KR, λ ) 1.54 Å), a pair of cross coupled Go ¨bel-mirrors for
monochromatization and parallel focusing, three pinholes (L 750 µm,
400 µm deﬁning the beam size and 1000 µm to suppress scattering
from the second pinhole) and a position sensitive two-dimensional area
detector (HI-STAR, Bruker AXS). The pinholes as well as the sample
and the detector were kept under vacuum during the experiment.
Transmissions were measured indirectly by using a glassy carbon
standard, which gives a very strong scattering signal that is proportional
to the transmitted intensity. The protein solution was contained in a
vacuum-sealed quartz glass capillary with a diameter of 1.5 mm (Anton
Paar, Graz, Austria), which was mounted on a Peltier-element (TCU
50, Anton Paar) to vary the temperature of the sample. The protein
was measured at three distinct temperatures: 4, 25, and 37 °C during
heating and again at 4 °C after cooling. After each temperature step,
measurements were taken with increasing acquisition times (starting
with 1000 s exposure time). For those experiments where the pH
dropped to 7.2 or below when the temperature was increased, we
observed time-dependent changes when comparing the data sets
measured during the ﬁrst 4 h. When the scattering signal did not change
anymore, measurements with longer acquisition times (∼3-6 h) were
done to improve the statistics. Only the data collected after the initial
equilibration time of up to 4 h was used for further evaluation.
In addition to the laboratory experiments, concentration dependent
measurements were carried out at the µ-Spot beamline
24 at BESSY II
(Berlin, Germany) using a two-dimensional MarMosaic CCD detector
(Mar 225, Mar, Evanston, U.S.A.). The beam was monochromatized
using a Si 111 double-crystal monochromator. Harmonics were
suppressed and the beam was focused by a curved mirror. The focusing
scheme of the beamline is designed to provide a divergence <1 mrad
(horizontally and vertically) and a beam diameter of roughly 20 µma t
a photon ﬂux of 1 × 109 s-1 at a ring current of 100 mA. The
experiments were carried out employing a wavelength of 1.003 Å. The
sample was a free ﬂoating droplet of protein solution in an ultrasonic
trap (Tec5, Oberursel, Germany). The ultrasonic trap (operating at 58
kHz and a sound level of 156 dB) creates a standing acoustic wave
between a transmitter and a reﬂector with equidistant nodal points in
which droplets can be held. The ultrasonic ﬁeld causes air-convection
which induces stirring of the droplet, thus ensuring a homogeneous
concentration distribution within the sample. The scattering patterns
were collected while the solvent slowly evaporated. We measured a 5
µL droplet of a 2 mg/mL suspension of rP172 80 mM Tris-HCl adjusted
to pH 7.8 at 25 °C. SAXS measurements were taken in 150 s intervals
until the solvent was completely evaporated (after 42 min). The
evaporation caused an increase in the protein concentration that was
calculated assuming a linear decrease of the droplet radius with time.
This is well in agreement with previous experimental observations.
25
The linear decrease of the radius corresponds to a constant evaporation
rate per surface area and time. Temperature control was not available
for this setup, so the experiments were carried out at room temperature
(∼20 °C), where the measured pH of the protein suspension was pH
7.9.
SAXSsEvaluation. Azimuthal integration of the isotropic two-
dimensional scattering signals using the program FIT2D (A. Hammer-
sley, ESRF, Grenoble, France) gave the scattered intensity as a function
of the modulus of the scattering vector Q (Q ) 4π sin(θ)/λ, where λ
is the wavelength and 2θ is the scattering angle). The scattering
intensities were then corrected for background scattering of the pinhole,
the capillary, and the solvent, taking into account the transmission of
the sample. Distilled water was used as a secondary standard to con-
vert the measured scattering intensities into scattering cross sections
per unit volume.
26
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the SAXS signal can be described by the Guinier approximation I(Q)
) I0exp(- Q2Rg
2/3) for small Q values (QRg < 1-2).
27 I(Q)i st h e
scattering cross section per unit volume, I0 is the limit of I(Q) for Qf0
and Rg is the radius of gyration deﬁned as Rg
2 ) (∫ Vr
2F(r)dV)/
(∫ VF(r)dV). Guinier plots (ln[I(Q)] vs Q2) and linear regressions were
used to evaluate the size parameter Rg. The errors were derived from
the calculated errors of the linear regressions in the Guinier plots which
were done for the Q-range between 0.13 nm-1 and 0.26 nm-1.
Modeling of the SAXS proﬁles was done using the following ﬁtting
function for monodisperse ellipsoids of revolution with the semiaxis
R1 ) R2 ) R and R3 ) Rε:





2[Q,r(R,ε,R)] sin(R)dR, where r(r,ε,R) ) R(sin2R+ε2 cos2R)1/2
and Fs(Q,r) ) 3[sin(Qr) - Qr cos(Qr)]/(Qr)3. N is the number of
independently scattering particles, ∆F the difference in the scattering
length densities of the particles and the solvent, and V corresponds to
the volume of each of the particles. We used oblate ellipsoids (ε < 1)
to model the scattering proﬁles of both rM179 and rP172. The data
were ﬁtted numerically with Mathematica 5.2 (Wolfram Research,
Champaign, IL, USA) by a least-squares method using the inverse error
of the scattering cross sections as weights. The parameter  red
2 28 was
used as an indicator for the quality of the ﬁt.  red
2 ) 1 corresponds to
an ideal ﬁt, where the average deviation between the ﬁtted function
and the data points is equal to the statistical error of the measured data.
We also compared our data with monodisperse spherical particles (ε
) 1) and spheres with a Gamma size distribution: f(R,γ,R) ) γRRR-1
exp(-γR)/Γ(R), I(Q,R,γ,R) ) ∫0
∞I[Q,R]f(R,γ,R)dR. Only for reasons
of comparison and to see how strongly a moderate polydispersity would
affect the results obtained with the monodisperse oblate model, we also
combined the two approaches (ﬁtting the parameters R and ε, R having
a Gamma size distribution with a ﬁxed polydispersity of 15%).
The molar mass Mw of the particles was calculated from the forward
intensity I0 ) N(∆F)2V2 ) Mwc(Fp -F s)2/(NAδp
2), which depends on
the protein concentration c, the mass density of the protein δp, and the
contrast between the solvent and the protein (Fp -F s)2, NA is
Avogadro’s number, and all other parameters have the same meaning
as described above. The following estimated average values for the
protein were used: δp ) 1.44 g/cm3, calculated using an approximation
that relates the molecular mass of the proteins (about 20 kDa for rM179
and rP172, see below) to their average mass density
29 and Fp ) 11.8
× 1014 m-2.
26 The buffer solution is primarily water with a scattering
length density of Fs ) 9.43 × 1014 m-2. Dividing the molar mass of
the particle Mw by the molar mass of the protein monomer MP, which
corresponds to 19574 g/mol and 20161 g/mol for rP172 and for rM179,
respectively,
30 gave the number n of amelogenin monomers per particle.
DLS. DLS data were collected using a DynaPro MSXTC/12
instrument with a gallium-arsenide diode laser (DynaPro-99-E-50) of
825.2 nm emission and programmable power. The instrument has a
temperature-controlled sample holder (precision of 0.1 °C) for a quartz
cuvette of 12 µL. Scattering data were collected at an angle of θ )
90° and processed using the software program DYNAMICS V6, version
6.3.40. A regularization algorithm was used to resolve for up to ﬁve
multimodal populations and their polydispersity, normalized to the mean
size of the peak and the hydrodynamic radius (RH). All RH data reported
here were modeled as isotropic spheres and result from mass-weighted
calculations. Mass-weighted calculations were used, because DLS is a
method that is very sensitive to large particle sizes. Polydispersity is
deﬁned as the relative standard deviation of RH measurements and
expressed as percent polydispersity (%PD). In agreement with a
previously developed convention based on comparing the %PD as
measured by DLS with gel electrophoresis analyses (SDS-PAGE)
31
and the ease of crystallization of proteins,
32 populations with a
polydispersity <15% are considered monodisperse, whereas those with
values >15% are considered polydisperse.
DLS data were collected for 2 mg/mL samples of rM179 and rP172
prepared in 80 mM Tris-HCl buffers adjusted to pH 7.2 at 37 °C. Data
were collected as a function of pH between pH 8 and pH 7 by increasing
the temperature from 7 to 43 °C. Each sample was allowed to equilibrate
at a given temperature for 5 min. The ensuing measurements consisted
of 20 acquisitions of 5 s each and were repeated three times at the
same temperature in 5 min intervals. Consequently, each sample was
kept at any given temperature for more than 20 min, allowing us to
check for particle size changes during the period of data collection at
each temperature. More than 95% of the measurements did not show
any sizable second population with a mass fraction >1%. A total of 8
out of 188 measurements for rM179 and rP172, which did show a
signiﬁcant second population, were disregarded for further evaluation,
because for each of them three other measurements within the 20 min
showed only one (100% by mass) population. Due to its very rare and
transient occurrence, the second population is not considered relevant
for the comparison with SAXS data collected using much longer
acquisition times of hours.
Results
In the investigated range of pH values between pH 7 and pH
8.1, both recombinant proteins formed aggregates that gave rise
to a pronounced small-angle scattering intensity in the observed
Q range of 0.13-2n m -1. Figure 1 shows a typical example for
a scattering proﬁle of rP172, measured at pH 8.1 and a
temperature of 4 °C.
A comparison of the experimental data with the scattering
function of monodisperse spheres (see the dotted gray line, R
) 10.5 nm, 0%PD) shows that such a simple model is not
suitable for describing the observed small-angle scattering
behavior. Monodisperse spherical particles would give rise to
oscillations in the small-angle scattering intensity, as illustrated,
which we did not observe. Taking into account a possible
deviation from the spherical shape, scattering functions for
ellipsoids were ﬁt to the data. A ﬁt with monodisperse oblate
(ﬂat) particles turned out to be in excellent agreement with the
measured scattering data (see the full gray line in Figure 1,  red
2
) 1.09, 1 being an ideal ﬁt). All scattering proﬁles of rP172
and rM179 that were measured at pH values larger than pH 7.2
Figure 1. Small-angle X-ray scattering (intensity I vs modulus of
the scattering vector Q) of rP172 (2 mg/mL) in 80 mM Tris-HCl at
4 °C and a measured pH value of 8.1. The experimental data,
collected with a Nanostar laboratory instrument, correspond to the
black dots with error bars and are not consistent with the scattering
function for monodisperse spheres (dotted gray line, calculated
for spheres of 10.5 nm in radius, 0%PD). The solid gray line shows
a ﬁt with the scattering function for monodisperse (0%PD) oblate
ellipsoids, which describes the data very well. The ﬁtted size
parameters were 5.5 and 12.2 nm for the shorter () rotational)
and longer half axes, respectively.
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oblate ellipsoids with a ratio of the shorter () rotational) axis
to the larger axis of about 0.45-0.5. Table 1 summarizes the
SAXS results obtained using the ellipsoid model. Note that the
mean values, which are averages of results for different pH and
temperature conditions, are just listed to facilitate the compari-
son. The differences between the maximum and the minimum
values for the size dimensions are relatively small as compared
to these mean values. Hence, no major changes in size or shape
were observed at pH values between 7.5 and 8.1 and temper-
atures of 4 and 25 °C. For both proteins, the smaller half axis
lies in the range of 5-6 nm, whereas the larger half axis
corresponds to 12-13 nm. We calculated that about 50-60
monomers assembled to build up one oblate at 4 °C. At 25 °C
(and somewhat lower pH values) the evaluated number of
monomers is in the range of 70-80. A typical volumetric
thermal expansion of proteins in the range of 1 × 10-3/K (see,
e.g., ref 33), which was not taken into account for the evaluation
at the two different temperatures, cannot explain the large
difference of about 25%. Nevertheless, because the number of
monomers was derived from extrapolating the SAXS curves to
Qf0 and under the assumption that all the protein molecules
build nanoparticles, these values should be interpreted with
caution. It is possible that the large increase in the evaluated
number of monomers between the two temperatures partially
arises from structural rearrangements which are not visible in
the accessible range of scattering angles.
Alternatively, a size distribution of spherical particles could
as well be responsible for the fact that predicted oscillations,
which are characteristic for monodisperse spheres, were not
observed. Indeed, the experimental data seen in Figure 1 are
also consistent with a size distribution of spherical particles.
However, a very large polydispersity of 33% would be required
for the predicted scattering curve to properly ﬁt the experimental
data (mean radius R ) 6.0 nm,  red
2 ) 0.69). As already
mentioned in the Introduction, this high polydispersity would
contradict previous DLS observations on the self-assembly of
recombinant amelogenins at comparable pH values. Neverthe-
less, we performed additional DLS studies on samples that were
prepared in exactly the same way as the ones used for the SAXS
measurements to obtain supporting information on the polydis-
persity of the protein suspensions. The results are summarized
in Table 2. Please note that the mean values, obtained by
averaging over different conditions, cannot be assigned to any
physical meaning and are just given for comparison. The
polydispersity values for rP172 and rM179 obtained from DLS
measurements are in the range of 10-17% for pH > 7.4,
reﬂecting the experimental conditions used for the SAXS
measurements reported in Table 1. This is just at the limit (15%)
of what would still be considered monodisperse in DLS
measurements and is much smaller than the 33% polydispersity
required to support a SAXS model of polydisperse spheres. For
comparison, we also tested a size distribution of spheres with a
ﬁxed polydispersity of 15% (ﬁtted mean radius R ) 8.2 nm).
However, such a model did not give any satisfying solution
( red
2 ) 7.5). Hence, the SAXS results together with the DLS
ﬁndings clearly provide evidence for a deviation from a spherical
shape.
In addition to the polydispersity values, the DLS measure-
ments also yielded information on the size of the protein
agglomerates. The hydrodynamic radii of about 15 nm (see
Table 2) are somewhat larger than the largest radius (longer
half axis) of the ellipsoidal model based on the SAXS results
(12-13 nm, Table 1). This difference will be discussed later
on.
Being aware that the size and shape information obtained
from the ﬁt with a monodisperse (0%PD) oblate model (SAXS
results in Table 1) might be affected by additional, superimposed
effects of a size distribution with a moderate polydispersity, as
obtained by means of DLS, we also tested a combination of
the two approaches: oblate ellipsoids with R1 ) R2 ) R and R3
) Rε, as before, but now R has a size distribution with a ﬁxed
polydispersity of 15%. The experimental data shown in Figure
1 can be very well described by such a model ( red
2 ) 0.71).
The obtained aspect ratios differ by less than 10% (ε ) 0.49
for 15%PD, ε ) 0.45 for 0%PD). These results strongly conﬁrm
the ﬁnding on the oblate shape. The model that has just been
described assumes that both size dimensions visible in SAXS
(R, εR) have the same polydispersity as measured for the
hydrodynamic radii using DLS. Because this assumption is not
necessarily true, the alternative model should just be seen as a
test allowing for taking into account the effect of a possible,
Table 1. Length of the Larger Half Axes (R1 ) R2), the Shorter Half Axis (R3), Aspect Ratio (R3/R1), and Number of Protein Monomers (n)
per Nano-Oblate (0%PD), Evaluated from SAXS Data Measured Using a Nanostar Laboratory Instrument
rP172
a (N ) 2) rM179
a (N ) 2)
pH
b T (°C) R1 ) R2 (nm) R3 (nm) R3/R1 nR 1 ) R2 (nm) R3 (nm) R3/R1 n
8.1 4 12.2 5.5 0.45 57 12.3 5.7 0.46 55
7.9 4 12.0 5.3 0.44 48 12.2 5.5 0.45 52
7.8 25 12.6 6.4 0.51 70
7.5 25 13.1 6.3 0.48 80 12.5 6.5 0.52 70
mean 12.5 5.9 0.47 64 12.3 5.9 0.48 59
max - min 1.1 1.1 0.07 32 0.3 1.0 0.07 18
a rP172 and rM179 in 2 mg/mL suspensions of 80 mM Tris-HCl buffer.
b The pH values given in the table were measured at the given temperatures.
Table 2. Polydispersity (PD) and Hydrodynamic Radii RH of the
Recombinant Amelogenins rP172 and rM179 Measured by Means
of DLS
rP172
a (N ) 3) rM179
a (N ) 2)
pH
b T (°C) PD (%) RH (nm) PD (%) RH (nm)
8.03 7 17.0 14.7 16.2 14.9
7.95 10 15.4 13.8 10.1 14.2
7.87 13 17.0 13.3 13.5 14.0
7.78 16 14.7 13.3 15.7 13.7
7.70 19 16.0 13.2 15.2 13.7
7.61 22 15.5 13.8 12.8 13.8
7.53 25 17.1 14.7 14.1 13.6
7.45 28 16.8 17.2 14.3 15.1
7.36 31 18.3 22.6 17.9 17.3
7.28 34 20.7 26.3
mean 16.4 15.2 15.0 15.7
max - min 3.6 9.4 10.6 12.7
a rP172 and rM179 in 2 mg/mL suspensions of 80 mM Tris-HCl buffer
adjusted to a pH of 7.2 at 37 °C.
b pH values shown are calculated on the
basis of the known temperature coefﬁcient for Tris-HCl.
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supports the results obtained with the monodisperse (0%PD)
oblate model.
Besides the shape of individual rP172 and rM179 nanopar-
ticles, their aggregation at pH values close to physiological
conditions, as described in the Introduction, is of major
importance for directing the growth of hydroxyapatite crystals.
Hence, we also studied pH-induced changes of amelogenin self-
assembly in suspension. The radius of gyration Rg was chosen
as a size parameter for the comparison of the SAXS proﬁles at
varying pH and temperature combinations. Rg averages all the
dimensions of the particle and is given by Rg ) R√2+ε
2 / 5 for
ellipsoids of revolution with the aspect ratio ε.
27 Figure 2 shows
the changes in Rg versus time during a series of measurements
taken while a change in pH was induced (see Materials and
Methods) through the heating and cooling of a 2 mg/mL
suspension of rP172 prepared in Tris-HCl buffer.
Due to the large temperature dependence of the Tris-HCl
buffer, the different temperatures correspond to different pH
values. At 4 °C and pH 8.1, the rP172 agglomerates had a radius
of gyration of 8.5 nm. During heating of the suspension and,
therefore, decreasing pH values, Rg increased. First, Rg rose a
moderate 6%, as the pH decreased from pH 8.1 to pH 7.5.
However, Rg then rose by the considerable amount of 23%, as
the pH was further decreased from pH 7.5 at 25 °Ct op H7 . 2
at 37 °C. After this abrupt change at 37 °C and pH 7.2, Rg
remained constant. The relatively large error bars for the radii
at pH 7.2 are due to deviations from the Guinier approximation
which is only valid for diluted systems, where the particles are
well separated from each other. This behavior indicates an
aggregation of the amelogenin nanoparticles at pH 7.2. The data
measured for pH 7.2 could also not be ﬁtted with the model of
isolated oblate ellipsoids. After cooling down to 4 °C (pH 8.1)
we observed a sudden decrease of Rg toward its original lower
level.
To distinguish pH-induced changes from temperature effects,
we tested protein suspensions in different buffer solutions.
Figure 3 shows the effect of changes in pH on the Rg of rP172
at a constant temperature of 25 °C. At pH values higher than
pH 7.2, the evaluated Rg of rP172 remained at a constant level
of about 9 nm. In contrast, at lower pH values, the radii
increased markedly on average (between pH 7.2 and pH 6.9),
although showing rather large differences between separate
measurements and larger error bars than those found at pH >
7.2. These variations indicate the beginning of an aggregation
of the nano-oblates, with decreasing pH. Of note, the data shown
in Figure 3 that were obtained at 25 °C reveal that this transition
takes place at the same pH value (i.e., pH 7.2) that was observed
for experiments carried out at 37 °C (as shown in Figure 2)
despite the difference in temperature. For rM179 we observed
the same behavior as for rP172, with an onset of aggregation
close to pH 7.2.
All of the results shown above were measured for suspensions
with a constant concentration of 2 mg/mL. Using an ultrasound
trap to levitate a droplet of an amelogenin suspension enabled
us to perform in situ synchrotron SAXS experiments while
increasing the protein concentration by means of solvent
evaporation. Figure 4 shows the time dependence of the Rg and
the protein concentration during a measurement of rP172 at 20
°C in a suspension with an initial concentration of 2 mg/mL
and an initial pH value of 7.9. Because the Tris-HCl buffer
concentration also increased during the evaporation, the pH of
the sample presumably changed toward elevated pH values
during the experiment. The radii were evaluated from the SAXS
data, whereas the concentrations were calculated assuming a
linear decrease of the droplet radius with time. Interestingly,
even though the concentration increased quite considerably, Rg
remained constant. Only shortly before drying completely, the
evaluated radii showed a sudden change (Figure 4). Furthermore,
the shape of the scattering curves (not shown) and, hence, the
shape of the nano-oblates did not change until shortly before
drying. It is possible that the individual oblates aggregated into
higher order structures (e.g., chains) when the concentration was
increased. However, the resolution of the used setup did not
allow for studying the aggregation behavior.
Figure 2. Radius of gyration Rg vs time determined from SAXS
measurements (Nanostar laboratory instrument) of a 2 mg/mL
suspension of rP172 prepared in 80 mM Tris-HCl buffer adjusted to
pH 7.2 at 37 °C. The temperature dependence of the buffer was used
to change the pH value by means of heating and cooling the sample.
The boxes with different gray scales correspond to different temper-
atures and measured pH values. At pH 7.2, Rg shows a remarkable
increase. Larger error bars indicate deviations from the Guinier
approximation, which is only valid for well-separated particles.
Figure 3. Radius of gyration Rg determined from SAXS measure-
ments (Nanostar laboratory instrument) of rP172 (2 mg/mL) in 80 mM
Tris-HCl buffers that were adjusted to different pH values. The
temperature during all the measurements was 25 °C. The increase
in Rg at pH values lower than pH 7.2 together with the increase in
the size of the error bars results from a pH-induced aggregation of
protein nanoparticles.
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Although amelogenin agglomerates in suspension have usu-
ally been referred to as nanospheres,
34 our combined SAXS and
DLS ﬁndings on rP172 and rM179 in aqueous solutions at pH
values higher than pH 7.2 suggest a nonspherical, oblate shape
with an aspect ratio of 0.45-0.5. SAXS is not a dynamic
measurement and averages over long acquisition times (hours
for the laboratory measurements). Therefore, the oblate shape
represents the average structure of the amelogenin agglomerates
which may well be ﬂexible in nature. To the best of our
knowledge, the current study provides for the ﬁrst time
quantitative results showing that recombinant amelogenins form
oblate rather than spherical particles in suspension, using an
approach that avoids potential artifacts that may result when
such particles are in contact with support materials (e.g., mica,
TEM grid or similar) typically used for AFM and TEM analyses.
The difference in the hydrodynamic radii as measured by DLS
and the largest dimension of the particles as measured by means
of SAXS, can be explained by a dense core and a loose shell
model of the monodisperse nano-oblates (see Figure 5). The
hydrophilic loose shell affects the mobility that is measured by
means of DLS but is not visible by SAXS, where the signal is
dominated by the hydrophobic core with much higher electron
density. This ﬁnding is in agreement with our previous DLS
and SAXS studies on rM179.
18 Additionally, the results of our
current study strongly support a model of monodisperse
amelogenin nanoparticles with an oblate core. The amphiphilic
nature of the investigated full-length recombinant amelogenins
and the folding of the proteins apparently favor the formation
of oblate nanoparticles. The similarity in shape and behavior
observed between rP172 and rM179 is consistent with the fact
that their primary structures are highly homologous, with nearly
identical N- and C-terminal domains.
1,3
Deviations from a spherical shape have previously also been
reported for amphiphilic copolymers, which assemble into
micellar structures with a dense core and a less dense corona,
similar to the structure of the amelogenin nanoparticles.
Depending on the chemical composition of the polymers not
only spherical cores but also oblate
35 or prolate
36 ellipsoidal
core structures were observed by means of SAXS.
Importantly, the oblate shape of amelogenin nanoparticles
may be of critical importance as it contributes to the explanation
for their assembly into anisotropic higher-order elongated (i.e.,
chain-like and ﬁber-like) structures, observed in vitro,
17,19–21
and predicted from SAXS/DLS data.
18 For high volume
fractions of amelogenin nanoparticles, as present in the forming
enamel, the oblate shape presumably induces an arrangement
with a preferred orientation. This would favor an aggregation
in preferred directions as compared to the formation of a
randomly connected network. Furthermore, the anisometric
dimensions suggest asymmetries in the surface properties of the
particles such as local variations in the surface charge. If special
parts of the surface of the oblate particles showed different
electrostatic interactions, this would also induce a directionality
of the aggregation. For instance, repulsive forces between
equally charged surfaces on the ﬂat part of the oblates or
pronounced attractive interactions between their more curved
sides would lead to a side by side assembly of the amelogenin
oblates. This could be an explanation for the above-mentioned
TEM and AFM observations of chain-like structures. Consistent
with the need for charge heterogeneity, the formation of such
elongated assemblies was shown for the full-length amelogenin
and not for cleaved amelogenins that lack the hydrophilic
C-terminus in several studies.
18–21 The full-length molecule
contains the charged hydrophilic C-terminal domain that differs
markedly from the remainder of the molecule that is primarily
hydrophobic. In a recent study, however, elongated assemblies
were observed by AFM to form over several days from dilute
suspensions (0.1 mg/mL total protein) of both recombinant full-
length (rH174) and truncated (rH163: that lacks 11 C-terminal
amino acids) human amelogenin, and their mixtures, at speciﬁed
pH values.
37 The authors of the latter study concluded that
assembly was primarily driven by the distribution of charge on
the surfaces of amelogenin nanoparticles, as we suggest based
on our present ﬁndings on the self-assembly of full-length
amelogenin in solution. Further investigations will be necessary
to ﬁnd out if and how the oblate shape and possible variations
in the surface charge affect the aggregation of amelogenin
Figure 4. (a) Radius of gyration Rg determined from in situ synchro-
tron SAXS measurements (µ-Spot beamline, BESSY II, HZB) of rP172
at 20 °C and a measured pH value of 7.9 and (b) calculated
concentration c of the protein suspension vs time. A 5 µL droplet
without any sample container was levitated by using an ultrasound
trap. Solvent evaporation led to an increase in the concentration, but
Rg was not affected over a wide range of concentrations. At very high
protein concentrations, shortly before drying, the evaporation rate
presumably differs from the function used to calculate the concentra-
tion (see also Materials and Methods). Hence, these values (dashed
part of the curve) should only be seen as rough estimates.
Figure 5. Revised core-shell model for the structure of amelogenin
nanoparticles based on SAXS and DLS measurements of rP172 and
rM179 at pH > 7.2. The SAXS measurements reﬂect the dimensions
of the more electron-dense oblate core (R1 ) R2, R3), whereas the
hydrodynamic radius RH describes the overall size, including the loose
shell, which affects the mobility of the particle as measured by means
of DLS. The scheme is consistent with the radii given in Tables 1
and 2.
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are underway to address the hypothesis that the oblate structure
plays an important role in the formation of linear chain-like
amelogenin aggregates.
Besides providing information on the shape of individual,
isolated amelogenin nanoparticles, SAXS results have also
allowed us to identify the conditions for the further assembly
of the nano-oblates into high-order elongated structures. We
would like to point out that the temperature and pH changes
that we used to perturb our in vitro system in a controlled way
are not intended to mimic similar changes in the biological
process. Instead, this approach was only applied to determine
the ﬁnal pH values and temperatures for which an aggregation
of the nano-oblates can be found. Previously, we reported on a
temperature-induced aggregation process for the recombinant
amelogenin rM179 and showed differences in the aggregation
of the full-length protein rM179 and the truncated protein
rM166. However, the Tris-HCl buffer used in that study
18 had
a strong temperature dependence and the effect of pH was not
systematically investigated. More recently, published DLS and
TEM studies which took into account the temperature depen-
dence of the buffers used indicated that the in vitro assembly
of recombinant amelogenins is pH-triggered rather than tem-
perature-dependent.
19 In very good agreement with these
ﬁndings, our current SAXS study again shows a sharp transition
point at a well-deﬁned pH value of pH 7.2 (Figures 2 and 3)
for full-length recombinant amelogenins, despite differences in
temperature. At higher pH values, the investigated amelogenins
build isolated nano-oblates, as supported by the ﬁtting of
appropriate shape models to the SAXS data (Figure 1) and the
derived model parameters (Table 1). At pH values lower or equal
to this limit the nano-oblates start to aggregate (see Figures 2
and 3). These results provide additional evidence that the
assembly into higher-order structures is mainly controlled by
the pH value. By raising the pH after keeping the protein
suspensions at pH 7.2 for several hours, we also found that, to
a large degree, the aggregation process is reversible. The
scattering proﬁles obtained after raising the pH value were again
in agreement with a model of isolated oblate particles. Moreover,
a quantitative analysis shows that the initial dimensions before
the aggregation were almost fully restored. Hence, the aggrega-
tion of the nano-oblates at pH values close to pH 7.2 and
temperatures from 25 to 37 °C is at least partially reversible.
This ﬁnding contradicts previous observations
18 where the
aggregation of rM179 was found to be nonreversible, however,
at the much higher temperature of 46 °C. The higher temperature
presumably induced nonreversible structural rearrangements
which were not observed for lower temperatures up to 37 °C.
Finally, the results obtained with the ultrasound trap (Figure
4) demonstrate that the amelogenin nano-oblates do not
signiﬁcantly change in size and shape, even if the concentration
of the suspension is dramatically increased up to more than 60
mg/mL. This ﬁnding supports the hypothesis that the results
discussed above, which were obtained using relatively low
amelogenin concentrations of 2 mg/mL, are not only relevant
for diluted in vitro systems but also for the early (secretory)
stages of enamel formation in vivo where concentrations of
enamel matrix proteins (90% amelogenins) are considerably
higher. The in vivo concentration of enamel matrix proteins has
been reported to be 200-300 mg/mL.
38,39 Furthermore, in
agreement with our new SAXS observations, previous AFM
studies
22 revealed that even amelogenin gels consist of as-
sembled amelogenin nanoparticles similar to the ones found in
suspensions.
When comparing our in vitro studies with the in vivo
situation, one should also keep in mind that the protein in vivo
does not self-assemble independently, but is under the inﬂuence
of initial mineralization events and growing mineral crystals.
In vitro mineralization studies have conﬁrmed the hypothesis
that amelogenins are able to promote the formation of aligned,
elongated hydroxyapatite crystals.
17,40,41 Importantly, however,
it was found that growing mineral crystals are only aligned when
the assembly of the protein and the growth of the crystals occur
simultaneously.
3,17 NMR studies on a truncated amelogenin
(LRAP) and its structure in the presence of hydroxyapatite (HA)
crystals have shown that its entire C-terminal domain is involved
in binding amelogenins to HA surfaces.
42,43 However, amelo-
genins lacking the hydrophilic C-terminus have also been shown
to interact with growing calcium phosphate crystals, affecting
their shape and size.
3,17,44,45 Nevertheless, considering that the
charged C-terminal is of high relevance for both protein-mineral
and the protein-protein interactions between the nano-oblates,
the growth of the mineral crystals during the early stages of
enamel formation will most likely affect the self-assembly
behavior of the full-length amelogenin in vivo. The current in
vitro study does not take into account the inﬂuence of mineral
crystals and cells, as present in the developing enamel. Elongated
HA crystals, interacting with amelogenins during the formation
of enamel, presumably even enhance the tendency of the protein
to assemble into elongated, chain-like structures. Moreover, in
the in vivo situation, a phosphate group at serine residue 16,
which is lacking in the investigated recombinant proteins rP172
and rM179, might also play an important role for the interaction
of amelogenins with HA mineral and their self-assembly. In
spite of these differences, the ﬁnding that recombinant full-
length amelogenins intrinsically form anisometric nanoparticles
which can assemble into anisotropic higher-order structures
highlights amelogenins as especially well-suited for guiding the
mineralization of enamel.
Conclusion
This study on the self-assembly of full-length recombinant
amelogenins rP172 and rM179 in suspensions provides new
evidence for an oblate shape for amelogenin nanoparticles, that
have been previously described as nanospheres, and their further
aggregation at pH values close to those found under physi-
ological conditions.
5,6 We propose that the observed anisometric
shape of full-length amelogenin nanoparticles in suspension is
a key factor associated with the formation of higher-order
anisotropic chain-like structures. These structures are believed
to play a critical role in regulating the organization of enamel
crystals on the nanoscale, resulting in the parallel arrangement
of elongated hydroxyapatite crystals. In addition to providing
new insights into the mechanisms behind the biomineralization
of dental enamel, our results should aid in the development of
bioinspired materials and approaches for enamel repair and
regeneration.
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